Consolidated Statement of Operations	12 Months Ended
	Dec. 31, 2019 USD ($) $ / shares shares
Income Statement [Abstract]
Revenue	$ 4,712,212
Cost of Goods Sold	2,990,716	[1]
Gross Profit	1,721,496
Operating Expenses
Research and development	174,257	[1]
Sales and marketing	6,222	[1]
General and administrative	14,325,078	[1]
Depreciation and amortization	7,567,184
Gain on sale of fixed assets	(98,410)
Total Operating Expenses	21,974,331
Net Operating Loss	(20,252,835)
Other Income (Expense)
Loss on conversion of debt	(2,640,000)
Net loss on extinguishment of debt	(434,774)
Foreign currency transaction gain	191,547
Interest expense	(8,399,663)
Other expense	(147,430)
Total Other Expenses	(11,430,320)
Net Loss Before Income Taxes	(31,683,155)
Deferred Tax Benefit	4,137,900
Net Loss	$ (27,545,255)
Loss per common share:
Basic | $ / shares	$ (0.57)
Diluted | $ / shares	$ (0.57)
Weighted-average shares outstanding:
Basic | shares	48,714,099
Diluted | shares	48,714,099

[1] These are exclusive of depreciation and amortization